| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/06/2005 | CN1634984A Alfalfa Na+/H+ reverse transporting protein, its encoding gene and application |
| 07/06/2005 | CN1634983A Method for preparing Griflola frondosa proteoglycan |
| 07/06/2005 | CN1634982A A portion of extracellular domain peptide segment of eukaryotic cells secretion expressed carcinembryonic antigen |
| 07/06/2005 | CN1634981A A plurality of antibiotic peptides, method for preparation and use thereof |
| 07/06/2005 | CN1634979A Ligand of NKG2D acceptor and use |
| 07/06/2005 | CN1634962A Process for preparing synergy factor in artificial blood, nucleotide sequence used thereby |
| 07/06/2005 | CN1209461C Enhanced protein production in higher plants by N-terminal fusion of a ubiquitin or a cucumber mosaic virus coat protein peptide |
| 07/06/2005 | CN1209374C Human Protein for promoting transform of 3T3 cell and its coding sequence |
| 07/06/2005 | CN1209373C Human protein with suppression to cancer cell growth and its coding sequence |
| 07/06/2005 | CN1209372C Human tumor relative gene CT120 in human 17p 13.3 area and coding protein thereof |
| 07/06/2005 | CN1209371C Vasoconstriction factor and preparation method as well as its application in pharmacy |
| 07/06/2005 | CN1209370C New human protein with cancer inhibiting function and its encoding sequence |
| 07/06/2005 | CN1209369C Cell death inducing protein and its coding sequence and use |
| 07/06/2005 | CN1209171C Hydrophobic muticomponent heparin conjugates, preparing method and use thereof |
| 07/06/2005 | CN1209165C Method for cell adhesion and wound healing |
| 07/06/2005 | CN1209164C Compositions comprising DNA damaging agents and P53 |
| 07/06/2005 | CN1209163C Meningococcal vaccine and its preparing method |
| 07/05/2005 | US6914135 Kunitz domain polypeptide zkun10 |
| 07/05/2005 | US6914134 Feline calicivirus genes and vaccines in particular recombinant vaccines |
| 07/05/2005 | US6914132 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/05/2005 | US6914131 Neisserial antigens |
| 07/05/2005 | US6914130 Compositions and methods for the diagnosis and treatment of tumor |
| 07/05/2005 | US6914127 A tetramer-free, stroma-free, crosslinked, polymerized hemoglobin from human blood; nontoxic |
| 07/05/2005 | US6914126 Crosslinking agent reacts with reactive pendant groups existing on the keratin molecules to produce biocompatible heterogenous proteinaceous networks crosslinked with the heterogenous crosslinker |
| 07/05/2005 | US6914125 Scramblase 2 |
| 07/05/2005 | US6914124 Tetracycline-regulated transcriptional activator fusion proteins |
| 07/05/2005 | US6914123 Hairpin peptides with a novel structural motif and methods relating thereto |
| 07/05/2005 | US6914049 IGF-binding protein-derived peptide or small molecule |
| 07/05/2005 | US6914047 Secreted protein HEMAE80 |
| 07/05/2005 | US6914046 Administering human growth hormone having a specific amino acid sequence to cancer patients who are resistant to, or at risk of developing a resistance to a NF-kappa B-activating cytotoxic molecule |
| 07/05/2005 | US6914044 Compounds and methods for modulating cell adhesion |
| 07/05/2005 | US6914043 Frozen food products comprising anti-freeze protein (AFP) type III HPLC 12 |
| 07/05/2005 | US6913926 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner |
| 07/05/2005 | US6913918 Isolated polypeptide |
| 07/05/2005 | US6913909 Nucleotide sequences coding for the thrE gene and process for the enzymatic production of L-threonine using coryneform bacteria |
| 07/05/2005 | US6913908 Methods of making L-amino acids in coryneform using the sigE gene |
| 07/05/2005 | US6913907 Enterococcus faecalis polynucleotides encoding EF059 |
| 07/05/2005 | US6913906 Thaumatin protein for use in intensifying food flavor |
| 07/05/2005 | US6913905 Regulatory sequences functioning in filamentous fungi |
| 07/05/2005 | US6913904 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
| 07/05/2005 | US6913903 Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| 07/05/2005 | US6913892 Method of obtaining compositions comprising Y4 specific compounds |
| 07/05/2005 | US6913891 Comprises myeloid terminal differentiation (MYD) polypeptide for diagnosis and treatment of leukemia and cell proliferative disorders; antisense agents |
| 07/05/2005 | US6913883 IGF-1 receptor interacting proteins |
| 07/05/2005 | US6913880 Method for determining transcription factor activity and its technical uses |
| 07/05/2005 | US6913757 Live, avirulent strain of V. anguillarum that protects fish against infection by virulent V. anguillarum and method of making the same |
| 07/05/2005 | US6913755 Amino acid substituted DNA sequences for use as vaccines against streptococcus |
| 07/05/2005 | US6913754 Renibacterium salmoninarum vaccine |
| 07/05/2005 | US6913752 Characterized by the loss of its capability to reproductively replicate in human cell lines. |
| 07/05/2005 | US6913751 Recombinant avian herpesvirus useful in vaccine production |
| 07/05/2005 | US6913750 Therapeutic compounds structurally-linked to bacterial polypeptides |
| 07/05/2005 | US6913749 Immunogenic polypeptide comprising a self Immunoglobin E (IgE) portion and a non-self IgE portion, to induce an anti-self IgE response in a mammal; treating diseases such as allergies |
| 07/05/2005 | US6913745 Passive immunization of Alzheimer's disease |
| 07/05/2005 | CA2280875C Remedies for lymphocytic tumors |
| 07/05/2005 | CA2215793C Use of neuronal apoptosis inhibitor protein (naip) |
| 07/05/2005 | CA2192683C Filtration |
| 07/05/2005 | CA2127463C Biodegradable polymers for cell transplantation |
| 07/05/2005 | CA2123811C Type i and type ii surface antigens associated with staphylococcus epidermidis |
| 06/30/2005 | WO2005059564A1 Rbp4 in insulin sensitivity/resistance, diabetes, and obesity |
| 06/30/2005 | WO2005059562A2 Diagnostic and therapeutic use of the human hif3alpha gene and proteins for neurodegenerative diseases |
| 06/30/2005 | WO2005059550A1 Dna encoding snorf138 and uses thereof |
| 06/30/2005 | WO2005059546A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 35 (gpr35) |
| 06/30/2005 | WO2005059505A2 Method and kit for the genotypification of hla-b27 based on real time pcr |
| 06/30/2005 | WO2005059173A1 Lac9 chimeric receptor and uses thereof |
| 06/30/2005 | WO2005059147A2 Plants having modified growth characteristics and method for making the same |
| 06/30/2005 | WO2005059145A1 Method to increase salt tolerance in plants |
| 06/30/2005 | WO2005059143A1 Pgro expression units |
| 06/30/2005 | WO2005059142A1 Novel chimeric plasminogen activators and their pharmaceutical use |
| 06/30/2005 | WO2005059140A1 Transgenic plants with reduced level of saturated fatty acid and methods for making them |
| 06/30/2005 | WO2005059137A1 Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |
| 06/30/2005 | WO2005059136A2 Dna-sequence and recombinant production of group 4 major allergens from cereals |
| 06/30/2005 | WO2005059133A2 Combination therapy associating a tgf-breta antagonist with a chemiotherapeutic agent |
| 06/30/2005 | WO2005059131A2 Protein binding miniature proteins and uses thereof |
| 06/30/2005 | WO2005059124A2 Isozyme-specific antagonists of protein kinase c |
| 06/30/2005 | WO2005059123A2 Pp2a/bgamma subunits, modulators thereof, and their uses in the treatment of mental disorders |
| 06/30/2005 | WO2005059101A2 Novel sodium channel |
| 06/30/2005 | WO2005059093A2 P ef-tu expression units |
| 06/30/2005 | WO2005058968A1 A method to make a peptide-carrier conjugate with a high immunogenicity |
| 06/30/2005 | WO2005058965A1 Methods and compositions for inhibiting c-met dimerization and activation |
| 06/30/2005 | WO2005058960A1 Cytochrome c protein and assay |
| 06/30/2005 | WO2005058959A2 Treatment of viral infections |
| 06/30/2005 | WO2005058958A2 Novel glp-1 analogues linked to albumin-like agents |
| 06/30/2005 | WO2005058957A2 Ztnf 12, a tumor necrosis factor |
| 06/30/2005 | WO2005058956A1 Cytokine binding domains |
| 06/30/2005 | WO2005058955A1 Analogues of glp-1 |
| 06/30/2005 | WO2005058954A1 Novel glp-1 compounds |
| 06/30/2005 | WO2005058953A2 Ogh fusion polypeptides and therapeutic uses thereof |
| 06/30/2005 | WO2005058952A2 Ztnf13, a tumor necrosis factor |
| 06/30/2005 | WO2005058951A1 Sugar chain-lacking hepatocyte growth factor |
| 06/30/2005 | WO2005058950A2 Methods for generating immunity to antigen |
| 06/30/2005 | WO2005058949A1 Protein separation device |
| 06/30/2005 | WO2005058948A1 Lsa-5 liver stage and blood stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria |
| 06/30/2005 | WO2005058947A1 Yeast strains with improved fructose fermentation capacity |
| 06/30/2005 | WO2005058946A2 Methods for enhancing expression of recombinant proteins |
| 06/30/2005 | WO2005058945A2 Gene variants coding for proteins from the metabolic pathway of fine chemicals |
| 06/30/2005 | WO2005058944A2 Immunogenic peptides fragments of xage-1 |
| 06/30/2005 | WO2005058942A1 Refolded membrane protein in monodisperse form |
| 06/30/2005 | WO2005058938A2 Helical synthetic peptides that stimulate cellular cholesterol efflux |
| 06/30/2005 | WO2005058937A2 A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1 |
| 06/30/2005 | WO2005058936A2 Dna sequence, and recombinant production of the grass pollen allergen lol p 4 |